Rosie

Rosie is a dog who was diagnosed with skin cancer. Her owner, Paul Conyngham, an Australian AI specialist, learned of her terminal diagnosis and decided to leverage his expertise to create a personalized vaccine. Conyngham utilized artificial intelligence tools to design an mRNA vaccine tailored to Rosie's specific cancer. The story has gained widespread attention recently due to the apparent success of the experimental treatment, with reports indicating a reduction in Rosie's tumors. This case is newsworthy because it highlights the potential of AI in personalized medicine, even when applied by individuals without formal scientific training. While presented as a possible breakthrough, experts urge caution, emphasizing the need for rigorous scientific validation and further research before such treatments can be considered widely applicable or safe. The case underscores the growing intersection of AI and healthcare, raising both excitement and concerns about accessibility and regulation.